-
-
-
-
-
-
-
Abeona Therapeutics (ABEO) Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
-
-
-
-
-
-
-
Abeona Therapeutics Provides Regulatory Update on Pz-cel
-
-
-
-
-
-
-
Abeona Therapeutics (ABEO) Enters $50M Credit Facility
-
-
-
-
-
-
-
Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program in Infantile Batten Disease
-
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

